This weekend our Clinical Manager, Tetiana Kovtiukh, visited the UENPS (Unition of European Neonatal & Perinatal Societies) congress in Krakow, Poland. UENPS mission is to develop the European neonatal and perinatal care and the overall goal is to develop the quality in care through integrating, coordinating, and adding successes and knowledge. Not only European actors take part in this congress, but representatives from all over the world. We did a short interview with Tetiana to summarize the weekend.

What is your impression of this year’s UENPS congress?
It was an intensive weekend and a lot to take in, both from discussions, presentations, and conversations. I have had the opportunity to speak with key opinion leaders from all over the world, for instance from the U.S., India, and Germany. I have also listened to many interesting presentations. All in all, it was a very good congress!

What is your goal with taking part in various congresses and conferences?
The goal is for me to create an understanding of the latest developments within the care of respiratory disorders. With this understanding I can then contribute with clinical knowledge to Neola Medical. Congresses and conferences are also an opportunity for me to create new connections and strengthen the company’s clinical network. During this weekend’s congress I had the opportunity to create a good basis for the continuous network creation. For instance, I met Silke Mader, chairman of the board of EFCNI (European Foundation for the Care of Newborn Infants), who told me more about the foundations work helping both preterm born infants, newborns, and their parents. Congresses and conferences are therefore an opportunity to build a clinical network for the company that consists not only of key opinion leaders, but also foundations that support patients and their parents.

What was the most interesting part of this congress?
What I thought was most interesting was to listen to the presentations, since this gave me a greater understanding of the care of preterm born infants, how scientific research have developed the last couple of years, and the utilization of new technologies. This can also be connected to the development of Neola® and it is therefore important to understand the latest research, the innovations, and the key opinion leaders’ opinions. It was also interesting to hear presentations from the patients’ point of view. For example, Juliëtte Komphuis and Mandy C. Daly shared their experiences of being born preterm respectively being the mother of a preterm born baby and the consequences this might involve. I was impressed to hear their stories about experiencing the care, and this increased my understanding of what possibilities there are with new medicine technology to improve quality of life and the care of this sensitive patient group.